Philip Tagari

Philip Tagari, Chief Scientific Officer of insitro, and Vijay Pande discuss the transformative power of drug discovery, evolution of the process with AI, and the future of the industry. Topics include AI-enabled drug engineering, personalized healthcare, and blending tech and life sciences for optimal results.